Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine

Rumfield et al.

  • Journal for ImmunoTherapy of Cancer
  • June 2020

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors

Albershardt et al.

  • June 2020

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Algazi et al.

  • Clinical Cancer Research
  • June 2020

A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors

Yamauchi et al.

  • bioRxiv
  • June 2020

Immunotherapy of CT26 Murine Tumors Is Characterized by an Oligoclonal Response of Tissue-Resident Memory T Cells Against the AH1 Rejection Antigen

Stringhini et al.

  • European Journal of Immunology
  • May 2020

Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient

Franco-Luzon et al.

  • Cancers
  • April 2020

Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma

Mitra et al.

  • Nature Communications
  • April 2020

Neutrophil Expansion Defines an Immunoinhibitory Peripheral and Intratumoral Inflammatory Milieu in Resected Non-Small Cell Lung Cancer: A Descriptive Analysis of a Prospectively Immunoprofiled Cohort

Mitchell et al.

  • Journal for ImmunoTherapy of Cancer
  • April 2020

Neoadjuvant Immunotherapy Leads to Pathological Responses in MMR-proficient and MMR-deficient Early-Stage Colon Cancers

Chalabi et al.

  • Nature Medicine
  • April 2020